could glp-1 be the next mental health drug Prospects of Therapies for Addiction and Comorbidities-Quo Vadis?: A Review GLP-1 Medications and Mental Health:
Description
Critical nodes in signalling pathways: Insights into insulin action
Int J Mol Sci 2022, 23(23)
Hospitals clearly are feeling the impact from the growing use of GLP-1s and widespread weight loss could affect providers operations downstream
19,103 However, a prominent adverse effect of TZDs is weight gain, thought to be primarily caused by a rise in body fat and retention of fluids
Programs that address only weight will be evaluated against programs that address weight and its downstream burden
Every peptide in the GLP-1 family works by binding to specific receptors on cells throughout the body
